Closing Bell: Nervgen Pharma Corp down on Friday (NGEN)

Today, shares of Nervgen Pharma Corp opened at $2.71 and closed at $2.69. It traded at a low of $2.51 to a high of $2.85.

Share prices eased -1.82 percent from the previous day's close of $2.74.

Today across North America, the TSX Composite closed -0.30% at 21875.79, the S&P 500 closed 0.09% at 5482.87, the Dow Jones Industrial Average closed 0.09% at 39164.06 and the Nasdaq Composite closed 0.30% at 17858.68.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 129,909 shares was traded during the last trading day, with total trades of 168, with an average volume of 125,035 over the last 5 days.

Trading across the entire TSX-V saw 2,599 price advancers against 2,604 declines and 117 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 60.12 percent in 52 weeks, while they have decreased -0.37% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $191.60 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..